CapsoVision, Inc. (CV) vs Sanara MedTech Inc. (SMTI)
A side-by-side comparison of CapsoVision, Inc. and Sanara MedTech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CV
CapsoVision, Inc.
$6.50HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
SMTI
Sanara MedTech Inc.
$35.00HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
Total return — CV vs SMTI
growth of $100 · dividends reinvested · last 1yCV +88.3% (+88.3%/yr)SMTI +24.7% (+24.7%/yr)CV compounded faster over this window
CV SMTI
CV vs SMTI: by the numbers
- •CV is the larger company ($325M vs $322M market cap).
- •Both run net losses; SMTI's is the smaller (-29.15% vs -214.74% net margin).
Metrics side by side
Valuation
| Metric | CV | SMTI |
|---|---|---|
| Forward P/E | N/A | 184.21 |
| P/S ratio | 23.39 | 2.93 |
| P/B ratio | 24.68 | 40.51 |
| EV / EBITDA | N/A | 27.80 |
| FCF yield | N/A | 1.40% |
Profitability
| Metric | CV | SMTI |
|---|---|---|
| Gross margin | 50.88% | 91.33% |
| Operating margin | -188.25% | 9.36% |
| Net margin | -214.74% | -29.15% |
| ROE | -226.56% | -403.03% |
| ROIC | -164.32% | 18.15% |
Growth (annualized)
| Metric | CV | SMTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 40.06% |
| Total return CAGR (5Y) | N/A | 0.35% |
Go deeper
Dig into the metrics
CapsoVision ROESanara MedTech ROECapsoVision operating marginSanara MedTech operating marginCapsoVision revenue growthSanara MedTech revenue growthCapsoVision free cash flowSanara MedTech free cash flow
CapsoVision & Sanara MedTech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.